Drug short opens new care play

Posted 31 July 2026 AM

A shortage of Ventolin Nebules is providing an opportunity to educate asthma patients about new care guidelines, the National Asthma Council (NAC) said.

GSK’s Ventolin Nebules (salbutamol sulfate) 5mg/2.5mL inhalation solution ampoules are unavailable until 17 August, while the 2.5mg/2.5mL ampoules have limited availability until 21 December, because of an “unexpected increase in demand due to other sponsors unable to supply”, the TGA said.

To see the whole article please log in.

Simon Webster

Log in with your member email for full access.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Email

Retype password

Not a member? Sign up here